Interactive Self-Management Augmented by Rehabilitation Technologies
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Feb 2, 2021
Trial Information
Current as of June 20, 2025
Completed
Keywords
ClinConnect Summary
In this study, the investigators will take 30 stroke survivors and have them participate in a 3-month study consisting of screening, assessments, goal setting, health coaching, EMA surveys, and feedback on how to improve the study for a future expanded study.
After the research team consents and enrolls participants, participants will be randomized and complete screening, assessment, and training on the video conferencing system, training on the Status/Post and SMS. The screening measures and assessments that will be performed are: Participation Strategies Self-Efficacy Scale, PROMIS Self ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ischemic or hemorrhagic stroke (NIHSS scores ≤13)
- • aged ≥18
- • English-speaking
- • ≥3 months post-stroke
- • identified as having ≥1 chronic condition
- • mobile phone ownership.
- Exclusion Criteria:
- • previous neurologic or psychiatric disorder (e.g. dementia or schizophrenia)
- • Short Blessed Test score ≥9 (indicating severe cognitive impairment) (Katzman et al., 1983)
- • history of functional problems (pre-morbid modified Ranking Scale score ≥2) regardless of prior stroke
- • severe aphasia (Boston Naming Test ≤10) (Kaplan, Goodglass, \& Weintraub, 2001) or NIH Stroke Scale Aphasia subscale score ≥2.
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Louis, Missouri, United States
Patients applied
Trial Officials
Wing Wong, PhD
Principal Investigator
Washington University OT
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials